(Broad Institute). Leading edge sets (LES) from this analysis contained 955 genes, all of the the top 100 genes occurred most frequently in LES (Heatmap). Most enriched was Areg, which encodes amphiregulin and was present in 8 LES. In order to define LES genes, filters were applied to select from these genes; for the most recent Sanger COSMIC Cancer Genes census. (http://cancer.sanger.ac.uk/cancergenome/projects/ census/), for the 'inflammasome', Gene Ontology (GO) term annotated as 'inflammatory'. A total of 5 genes were annotated for both cancer and inflammation: Fcgr2b, Egfr, Tnfaip3, Fas and Myd88. (GSE20715_0H_VS_24H_OZONE_TLR4_KO_LUNG_DN, GSE20715_0H_VS_48H_ OZONE_TLR4_KO_LUNG_DN, GNF2_SERPINB5, GNF2_CDH3, DELYS_THYROID_CANCER_UP, PEDERSEN_METASTASIS_ BY_ERBB2_ISOFORM_1, GSE9988_LOW_LPS_VS_VEHICLE_TREATED_MONOCYTE_UP, GSE14769_UNSTIM_VS_120MIN_ LPS_BMDM_DN). Lgr5CreERT2 (n=3) re-challenged (R) with tamoxifen (arrow) (log-rank test). There was a significant difference in adenoma size, with the re-challenged group having a higher proportion of smaller adenomas (student's t-test, p<0.01). Lgr5-CreERT2 re-challenged with tamoxifen. There were no differences in adenoma appearances between genotypes following initial tamoxifen injection (Figure 3a) . Top row, widespread adenomatous change, with higher magnification (right). Middle row, adenomatous change with multiple foci of necrosis (black arrows). Lower row, right: large sessile adenomas on a background of diffuse adenomatosis with prominent cystic changes; marked cystic change (black arrowheads) and glands with necrosis (black arrows); disruption of adenoma structure (black star). Scale bars 100μm. 
Lgr5CreER
T2 adenoma organoids (days 4-6). a. Cultured adenomas incubated with EdU (2hrs) and then immune-labeled for DAPI, β-catenin, E-cadherin and EdU. In Ad-Cre negative culture, β-catenin and E-cadherin are co-localised at the cell membrane, and EdU positive cells are present in all areas of the adenoma, with some detection of Cre from Lgr5. In Ad-Cre positive there appeared fewer EdU positive cells in the area of the adenoma with loss of E-cadherin and increased β-catenin. Scale bar 50μm. b. Immuno-labeling with or without Ad-Cre treatment for DAPI, E-cadherin, Cre recombinase and CC3 (cleaved caspase 3). In Ad-Cre negative adenomas, variable CC3 labeling in outer and inner regions and prominent in necrotic cores by day 6. In Ad-Cre positive adenomas, CC3 positive cells were uncommon by day 6. Scale bar 50μm.
